Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Should You Buy?

Posted by Doug Wharley on Aug 12th, 2026

Target Healthcare REIT (LON:THRL – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 117 and last traded at GBX 112.96, with a volume of 96593 shares changing hands. The stock had previously closed at GBX 112.80.

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price target on shares of Target Healthcare REIT in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of GBX 101.

Get Our Latest Stock Report on THRL

Target Healthcare REIT Stock Down 0.0%

The stock has a fifty day moving average of GBX 110.16 and a 200-day moving average of GBX 106.57. The firm has a market capitalization of £695.82 million, a P/E ratio of 8.92, a PEG ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.